scholarly journals COVID-19 prevention with subcutaneous administration of the monoclonal antibodies casirivimab and imdevimab: Subgroup analysis in participants with cardiovascular disease and diabetes

2021 ◽  
Vol 242 ◽  
pp. 172-173
Author(s):  
Meagan P. O'Brien ◽  
Eduardo Forleo-Neto ◽  
Bret J. Musser ◽  
Flonza Isa ◽  
Kuo-Chen Chan ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Monoclonal Antibodies ◽  
Subgroup Analysis ◽  
Subcutaneous Administration

scholarly journals PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

2015 ◽  
Author(s):  
Amand F Schmidt ◽  
Lucy S Pearce ◽  
John T Wilkins ◽  
John P Overington ◽  
Aroon Hingorani ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Monoclonal Antibodies ◽  
Secondary Prevention ◽  
Primary And Secondary Prevention ◽  
Prevention Of Cardiovascular Disease

scholarly journals Subgroup analysis for the risk of cardiovascular disease with calcium supplements

2013 ◽  
Vol 2 (3) ◽  
Author(s):  
Loretta T Radford ◽  
Mark J Bolland ◽  
Greg D Gamble ◽  
Andrew Grey ◽  
Ian R Reid
Keyword(s):  
Cardiovascular Disease ◽  
Subgroup Analysis ◽  
Calcium Supplements

scholarly journals Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease

Heart ◽  
2021 ◽  
pp. heartjnl-2021-319629
Author(s):  
John-Paul Carter ◽  
Aroon D Hingorani ◽  
John Wilkins ◽  
Amand Floriaan Schmidt
Keyword(s):  
Cardiovascular Disease ◽  
Monoclonal Antibodies ◽  
Secondary Prevention ◽  
Primary And Secondary Prevention ◽  
Prevention Of Cardiovascular Disease
Sign in / Sign up

Export Citation Format

Share Document